Delivery Order SPE2DE24DA010-SPE2D626F69M9
- Not listed
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a delivery order valued at $5,495 on December 11, 2025, by the Defense Logistics Agency's Medical Supply Chain division. This fixed-price contract with economic price adjustment authority has a performance completion date of January 6, 2026, and will be performed in Santa Clara, California. The award carries no set-aside designation and was made through full and open competition, consistent with Abbott Vascular's...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a delivery order valued at $14,850 on November 14, 2025, by the Defense Logistics Agency's Medical Supply Chain division. This fixed-price delivery order with economic price adjustment provisions is scheduled for completion by November 19, 2025, and will be performed in Santa Clara, California. The award represents a child contract under Abbott Laboratories Inc.'s broader federal contracting portfolio and was made...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a delivery order valued at $24,350 by the Defense Logistics Agency's Medical Supply Chain on December 2, 2025, with an ultimate completion date of December 5, 2025. The contract is structured as a fixed-price delivery order with economic price adjustment provisions and carries no set-aside designation, reflecting Abbott's competitive positioning among qualified federal contractors. Performance will take place in...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a delivery order valued at $24,350 on November 25, 2025, by the Defense Logistics Agency's Medical Supply Chain division. This fixed-price delivery order with economic price adjustment is scheduled for completion by December 2, 2025, and will be performed in Santa Clara, California. The award utilized full and open competition with no set-aside designation, consistent with Abbott Vascular's established competitive...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, received a delivery order award valued at $5,695.00 from the Defense Logistics Agency's Medical Supply Chain on December 10, 2025, with an ultimate completion date of December 15, 2025. The contract utilizes a fixed-price structure with economic price adjustment pricing and was awarded without a set-aside designation through full and open competition. Performance will take place in Santa Clara, California, positioning the award...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, received a delivery order valued at $5,695.00 from the Defense Logistics Agency's Medical Supply Chain on December 11, 2025. This fixed-price delivery order with economic price adjustment authority will be performed in Santa Clara, California, with an ultimate completion date of January 6, 2026. The contract was awarded through full and open competition with no set-aside designation, reflecting Abbott's competitive...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a delivery order valued at $26,480.13 by the Defense Logistics Agency's Medical Supply Chain on December 1, 2025, with an ultimate completion date of December 4, 2025. This fixed-price delivery order with economic price adjustment carries no set-aside designation and will be performed in Santa Clara, California. The award represents a task order under Abbott's established relationship with the Defense Logistics...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a delivery order valued at $37,164.80 by the Medical Supply Chain division of the Department of Defense on June 18, 2025, with a completion date of June 24, 2025. The award is designated as a fixed-price contract with economic price adjustment and was issued without a set-aside, indicating full and open competition. Performance will be executed at Abbott's facility in Santa Clara, California. This delivery order...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, has been awarded a fixed-price delivery order valued at $5,695.00 by the Medical Supply Chain division of the Department of Defense. The contract, awarded on May 30, 2025, with an ultimate completion date of June 4, 2025, represents a delivery order under a larger indefinite delivery vehicle. This award was made through full and open competition with no set-aside designation. The place of performance is Santa Clara, California....
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, has been awarded a fixed-price delivery order valued at $5,695.00 by the Defense Logistics Agency's Medical Supply Chain division. The contract, issued on May 20, 2025, with an ultimate completion date of June 9, 2025, represents a child contract under Abbott Laboratories Inc.'s parent entity and will be performed in Santa Clara, California. This delivery order was awarded without a set-aside designation, indicating full and...
- SPE2DE24DA010Indefinite Delivery Contract
- SPE2DE24DA010-SPE2D626F69M9Delivery Order
Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a $5,495.00 fixed-price delivery order with economic price adjustment by the Defense Logistics Agency's Medical Supply Chain on December 11, 2025. This child contract is a delivery order with an ultimate completion date of January 6, 2026, and will be performed in Santa Clara, California. The award utilized full and open competition with no set-aside designation, reflecting Abbott's established competitive positioning as a critical supplier of cardiovascular medical technologies to federal healthcare systems. This delivery order is part of Abbott Vascular's broader engagement with the Defense Logistics Agency, which maintains a $117.1 million indefinite delivery contract vehicle with the company for comprehensive cardiovascular procedural packages including devices, instrumentation, accessories, and related medical technologies. Abbott Vascular has established itself as an essential supplier to the federal government's medical supply infrastructure through its provision of advanced cardiovascular implants, including stents, pacemakers, heart valves, left ventricular assist devices, and transcatheter valve repair systems, serving the Department of Defense, Department of Veterans Affairs, and other federal healthcare agencies across multiple Veterans Integrated Service Networks.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.5k | 12/10/25 |